Transcriptomics

Dataset Information

0

Beneficial effects of physical exercise and an orally active mGluR2/3 antagonist pro-drug on neurogenesis and behavior in an Alzheimer’s amyloidosis model


ABSTRACT: BCI-838 is a pro-drug whose active metabolite BCI-632 is an antagonist at the group II metabotropic glutamate receptor (mGluR2/3). Hippocampal dentate gyrus of four-month old mouse model of AD amyloid pathology (APP/PS1) were investigated via transcriptomics analysis following BCI-838 treatment and physical exercise. Findings demonstrate up-regulated brain-derived neurotrophic factor (BDNF), PIK3C2A of the PI3K-MTOR pathway, and metabotropic glutamate receptors, and down-regulated EIF5A of ketamine-modulating mTOR activity. Our study points to BCI-838 as a safe and orally active compound capable of mimicking the beneficial effect of exercise on AHN, learning behavior, and anxiety in a mouse model of AD neuropathology.

ORGANISM(S): Mus musculus

PROVIDER: GSE203554 | GEO | 2022/05/25

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-06-21 | GSE172402 | GEO
2023-03-08 | PXD034176 | Pride
2014-04-05 | GSE45813 | GEO
2024-05-28 | GSE268144 | GEO
2017-10-25 | GSE106100 | GEO
2020-10-02 | GSE158881 | GEO
2015-05-14 | GSE48278 | GEO
2024-06-12 | GSE217487 | GEO
2022-03-04 | GSE192521 | GEO
2015-05-14 | E-GEOD-48278 | biostudies-arrayexpress